Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 34, 2022 - Issue 7
299
Views
4
CrossRef citations to date
0
Altmetric
Research Article

COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling

, , , , , , , , , , , , , , , , & show all
Pages 832-838 | Received 25 Feb 2021, Accepted 25 May 2021, Published online: 04 Jun 2021

References

  • Batista, A., Antunes, B., Faveret, G., Peres, I., Marchesi, J., Cunha, J. P., Dantas, L., Bastos, L., Carrilho, L., Aguilar, S., Baião, F., Maçaira, P., Hamacher, S., & Bozza, F. (2020). Análise socioeconômica da taxa de letalidade da COVID-19 no Brasil - Nota Técnica 11 de 27/05/2020. https://sites.google.com/view/nois-pucrio/publica%C3%A7%C3%B5es#h.ijqa5msfttoq
  • Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., … Lane, H. C. (2020). Remdesivir for the treatment of Covid-19 — Final report. New England Journal of Medicine, 383(19), 1813–1826. https://doi.org/10.1056/NEJMoa2007764
  • Chan, K. S., Lai, S. T., Chu, C. M., Tsui, E., Tam, C. Y., Wong, M. M., M W Tse, T L Que, J S M Peiris, J Sung, V C W Wong, Yuen, K. Y. (2003). Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: A multicentre retrospective matched cohort study. Hong Kong Medical Journal, 9(6), 399–406.
  • Chen, X. P., Li, G. H., Tang, X. P., Xiong, Y., Chen, X. J., & Cao, Y. (2003). Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalized together. JAIDS Journal of Acquired Immune Deficiency Syndromes, 34(2), 242–243. https://doi.org/10.1097/00126334-200310010-00016
  • Chu, C. M., Cheng, V. C., Hung, I. F., Wong, M. M., Chan, K. H., Chan, K. S., Group, H. U. S. S. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252–256. https://doi.org/10.1136/thorax.2003.012658
  • Dandachi, D., Geiger, G., Montgomery, M. W., Karmen-Tuohy, S., Golzy, M., Antar, A. A. R., Llibre, J. M., Camazine, M., Díaz-De Santiago, A., Carlucci, P. M., Zacharioudakis, I. M., Rahimian, J., Wanjalla, C. N., Slim, J., Arinze, F., Kratz, A. M. P., Jones, J. L., Patel, S. M., Kitchell, E., … Chow, J. (2020). Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa1339
  • Dayer, M. R., Taleb-Gassabi, S., & Dayer, M. S. (2017). Lopinavir; A potent drug against coronavirus infection: Insight fromMolecular docking study. Archives of Clinical Infectious Diseases, 12(4), 1–7. https://doi.org/10.5812/archcid.13823
  • Del Amo, J., Polo, R., Moreno, S., Diaz, A., Martinez, E., & Arribas, J. R. (2020). Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: A cohort study. Annals of Internal Medicine, 173(7), 536–541. https://doi.org/10.7326/M20-3689
  • Desigualdades sociais por cor ou raça no Brasil. (2019). Estudos e Pesquisas - Informação Demográfica e Socioeconômica: https://biblioteca.ibge.gov.br/visualizacao/livros/liv101681_informativo.pdf
  • Elfiky, A. A. (2020). Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/10.1016/j.lfs.2020.117592
  • Ford, N., Vitoria, M., Rangaraj, A., Norris, S. L., Calmy, A., & Doherty, M. (2020). Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: Initial assessment. Journal of the International AIDS Society, 23(4), e25489. https://doi.org/10.1002/jia2.25489
  • Gervasoni, C., Meraviglia, P., Riva, A., Giacomelli, A., Oreni, L., Minisci, D., Atzori, C., Ridolfo, A., & Cattaneo, D. (2020). Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clinical Infectious Diseases, 71(16), 2276–2278. https://doi.org/10.1093/cid/ciaa579
  • Goes, E. F., Ramos, D. O., & Ferreira, A. J. F. (2020). Desigualdades raciais em saúde e a pandemia da Covid-19. Trabalho, Educação e Saúde, 18(3), e00278110. https://doi.org/10.1590/1981-7746-sol00278
  • Guan, W. J., Liang, W. H., Zhao, Y., Liang, H. R., Chen, Z. S., Li, Y.-m., Liu, X.-q., Chen, R.-c., Tang, C.-l., Wang, T., Ou, C.-q., Li, L., Chen, P.-y., Sang, L., Wang, W., Li, J.-f., Li, C.-c., Ou, L.-m., Cheng, B., … He, J.-x. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. European Respiratory Journal, 55(5). https://doi.org/10.1183/13993003.00547-2020
  • Guo, W., Ming, F., Dong, Y., Zhang, Q., Zhang, X., Mo, P., Feng, Y., & Liang, K. (2020). A Survey for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan, China.
  • Harter, G., Spinner, C. D., Roider, J., Bickel, M., Krznaric, I., Grunwald, S., Schabaz, F., Gillor, D., Postel, N., Mueller, M. C., Müller, M., Römer, K., Schewe, K., & Hoffmann, C. (2020). COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients. Infection, 48(5), 681–686. https://doi.org/10.1007/s15010-020-01438-z
  • Indicadores e Dados Básicos de Monitoramento Clínico. Ministerio da Saude, Brasil. http://indicadoresclinicos.aids.gov.br
  • Jockusch, S., Tao, C., Li, X., Anderson, T. K., Chien, M., Kumar, S., Russo, J. J., Kirchdoerfer, R. N., & Ju, J. (2020). A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19. Antiviral Research, 180, 104857. https://doi.org/10.1016/j.antiviral.2020.104857
  • Melchjorsen, J., Risor, M. W., Sogaard, O. S., O’Loughlin, K. L., Chow, S., Paludan, S. R., Ellermann-Eriksen, S., Hedley, D. W., Minderman, H., Østergaard, L., & Tolstrup, M. (2011). Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(4), 265–275. https://doi.org/10.1097/QAI.0b013e3182185276
  • Meyer, B., Basra, A., Aberle, S., Aberle, J., Robibaro, B., Wenisch, C., & Laferl, H. (2015). MERS-CoV disease associated ARDS - A case report. Critical Care Medicine, 43(12), 308. https://doi.org/10.1097/01.ccm.0000475056.21112.47
  • Novo Coronavírus (COVID-19) - Situação Epidemiológica. (2020). Sao Paulo. http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/doencas-de-transmissao-respiratoria/coronavirus/setembro/coronavirus300920_situacao_epidemiologica.pdf
  • Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M. H., Sarraf, P., & Djalali, M. (2020). Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. The Aging Male, 23(5), 1416–1424. https://doi.org/10.1080/13685538.2020.1774748
  • Ryan, C., Minc, A., Caceres, J., Balsalobre, A., Dixit, A., Ng, B. K., Schmitzberger, F., Syed-Abdul, S., & Fung, C. (2020). Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms. The American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2020.09.017
  • Sachdev, D., Mara, E., Hsu, L., Scheer, S., Rutherford, G., Enanoria, W., & Gandhi, M. (2021). COVID-19 Susceptibility and outcomes among people living with HIV in San Francisco. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86, 1, 19–21. https://doi.org/10.1097/QAI.0000000000002531
  • Sigel, K., Swartz, T., Golden, E., Paranjpe, I., Somani, S., Richter, F., De Freitas, J. K., Miotto, R., Zhao, S., Polak, P., Mutetwa, T., Factor, S., Mehandru, S., Mullen, M., Cossarini, F., Bottinger, E., Fayad, Z., Merad, M., Gnjatic, S., … Glicksberg, B. S. (2020). Coronavirus 2019 and people living with human immunodeficiency virus: Outcomes for hospitalized patients in New York city. Clinical Infectious Diseases, 71(11), 2933–2938. https://doi.org/10.1093/cid/ciaa880
  • Solar, O., & Irwin, A. (2010). A conceptual framework for action on the social determinants of health. Social Determinants of Health Discussion Paper 2 (Policy and Practice). https://www.who.int/sdhconference/resources/ConceptualframeworkforactiononSDH_eng.pdf
  • Souza, C. D. F., Paiva, J. P. S., Leal, T. C., Silva, L. F. D., & Santos, L. G. (2020). Spatiotemporal evolution of case fatality rates of COVID-19 in Brazil, 2020. Jornal Brasileiro de Pneumologia, 46(4), e20200208. https://doi.org/10.36416/1806-3756/e20200208
  • Ssentongo, P., Heilbrunn, E. S., Ssentongo, A. E., Advani, S., Chinchilli, V. M., Nunez, J. J., & Du, P. (2021). Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis. Scientific Reports, 11(1), 6283. https://doi.org/10.1038/s41598-021-85359-3
  • Szklo, M., & Nieto, F. J. (2004). Epidemiology beyond the basics. Jones and Bartlett.
  • Tancredi, M. V., & Waldman, E. A. (2014). Predictors of progression to AIDS after HIV infection diagnosis in the pre- and post-HAART eras in a Brazilian AIDS-free cohort. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108(7), 408–414. https://doi.org/10.1093/trstmh/tru078
  • Vizcarra, P., Perez-Elias, M. J., Quereda, C., Moreno, A., Vivancos, M. J., Dronda, F., Casado, J. L., Moreno, S., Pérez-Elías, M. J., Fortún, J., Navas, E., Quereda, C., Dronda, F., Del Campo, S., López-Vélez, R., Cobo Reinoso, J., Casado, J. L., Moreno, A., Norman, F., … Vizcarra, P. (2020). Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort. The Lancet HIV, 7(8), e554–e564. https://doi.org/10.1016/S2352-3018(20)30164-8
  • Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.